Despite concerns about on-target toxicity of anti-TDP-43 antibodies due to the essential role of TDP-43 for cellular survival, we only detected unexpected safety risks of highly immunogenic N-terminal peptides, presumably due to anaphylaxis in one of four genetic backgrounds tested. This evidence concerns the gene TARDBP and anaphylaxis.